Tata Group in talks with Moderna to launch COVID-19 vaccine in India As per the government's norms, it is mandatory for a foreign vaccine-making firm to conduct at least a Phase-3 trial with Indian volunteers even if it is approved outside India BusinessToday.In | January 25, 2021 | Updated 11:00 IST Last year in January, Moderna received fundings from the Coalition for Epidemic Preparedness Innovations to develop a vaccine against the COVID-19 virus Tata Group's new healthcare venture, Tata Medical and Diagnostics Ltd (TataMD) has started exploratory talks with US biotechnology firm Moderna for a partnership to launch its COVID-19 vaccine in India. As per the government's norms, it is mandatory for a foreign vaccine-making firm to conduct at least a Phase-3 trial with Indian volunteers even if it is approved outside India.